Skip to main content
IMMP logo

Immutep Limited

IMMPNASDAQHealthcareBiotechnology

$3.15Today:- (-)1Y +57.71%

As of Oct 27, 2026 close

Market cap
$463.55M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.29$9.18
Volume (live)
-
Avg. volume (3M)
20.14K

Immutep (IMMP) Cash Flow Statement

In fiscal 2026 (fiscal year ended Jun 30, 2026), Immutep used AUD 54.25M of cash in operating activities and spent AUD 92.93K on capital expenditures. That left free cash flow of −AUD 55.56M.

Immutep Cash Flow Statement Analysis

Values in millions AUD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Immutep Limited (IMMP) - Annual data in millions AUD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Operating Activities
Net Income-77.57-61.43-42.72-39.90-32.21-29.90-13.47-18.34-12.75-9.37
Depreciation & Amortization2.422.392.262.062.062.072.081.881.811.70
Deferred Income Tax0.000.000.00-4.990.00-7.29-6.11-5.71-9.79-0.22
Stock Based Compensation0.001.161.802.001.491.701.721.582.260.86
Change in Working Capital16.22-8.543.990.76-1.56-1.990.09-0.35-0.25-2.24
Change in Accounts Receivable0.45-2.520.60-1.61-2.25-2.831.90-1.76-1.24-2.03
Change in Inventory0.000.000.000.000.810.000.000.000.000.65
Change in Accounts Payable2.720.000.543.271.441.38-2.131.401.081.38
Change in Other Working Capital13.06-6.02-32.13-36.51-31.01-18.400.320.02-0.09-1.59
Other Operating Activities4.684.37-0.16-0.29-0.0110.484.845.6510.940.75
Net Cash from Operating Activities-54.25-62.05-34.82-35.36-30.23-17.64-10.84-15.29-7.78-8.51
Investing Activities
Capital Expenditures-0.09-0.05-0.03-0.08-0.02-0.02-0.02-0.04-0.01-0.01
Purchases of Investments-5.000.00-20.090.000.000.000.000.000.000.00
Sales/Maturities of Investments61.580.00-0.900.000.000.000.000.000.000.00
Other Investing Activities-0.03-38.49-0.900.020.000.000.00-0.04-0.01-0.01
Net Cash from Investing Activities56.46-38.53-21.02-0.08-0.02-0.02-0.02-0.04-0.01-0.01
Financing Activities
Debt Repayment-0.21-0.27-0.23-0.21-0.22-0.21-0.080.000.000.00
Common Stock Issued0.00-0.16100.2980.0852.9855.0422.034.8716.970.00
Other Financing Activities-0.21-0.25-4.83-3.85-2.43-2.36-1.473.141.44-0.01
Net Cash from Financing Activities-0.21-0.5395.1876.0250.3352.6820.488.0118.40-0.01
Summary
Effect of Forex Changes on Cash-4.526.73-0.972.84-0.67-0.750.130.410.62-0.12
Net Change in Cash0.78-94.3838.3740.5819.4035.029.75-6.9111.24-8.64
Cash at Beginning of Period67.41161.79123.4280.0060.5926.3216.5723.4812.2420.88
Cash at End of Period63.6767.41161.79123.4280.0060.5926.3216.5723.4812.24
Free Cash Flow-55.56-62.10-34.85-35.44-30.25-17.66-10.86-15.33-7.79-8.51
Supplemental Disclosures
Interest Paid-0.040.030.020.090.01----
Income Taxes Paid----0.000.00----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Immutep Cash Flow

What is Immutep's free cash flow?

Immutep had negative free cash flow of AUD 55.56M in fiscal 2026 (fiscal year ended Jun 30, 2026), operating cash flow of −AUD 54.25M minus AUD 92.93K of capital expenditures.

How much does Immutep spend on capital expenditures?

Immutep spent AUD 92.93K on capital expenditures in fiscal 2026, compared with AUD 45.77K a year earlier.

Does Immutep pay dividends or buy back shares?

Immutep's cash flow statement for fiscal 2026 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition